Parenting a Child With IBD: A Guide for Families

When your child is diagnosed with inflammatory bowel disease (IBD), whether Crohn’s disease or ulcerative colitis, the entire family begins navigating a new reality combining medical complexity with everyday childhood challenges. Understanding how IBD affects your child’s body, what triggers flare-ups, and how to support their physical and emotional wellbeing helps build a stable foundation for long-term management.

Understanding paediatric IBD

IBD in children involves chronic inflammation of the digestive tract affecting growth, development, and daily life. In Crohn’s disease, inflammation can occur anywhere from mouth to anus and may extend through multiple bowel wall layers. Ulcerative colitis affects the colon and rectum, with inflammation limited to the innermost lining. Both conditions follow a relapsing and remitting pattern, meaning active disease periods (flares) alternate with reduced symptoms (remission). Treatment aims to control inflammation, allow normal growth, and maintain remission.

Why inflammation matters for growing children

Children with IBD face unique challenges because ongoing inflammation interferes with nutrient absorption and energy availability during critical growth periods. Inflammatory cytokines, particularly tumour necrosis factor alpha (TNF-alpha) and interleukin-6, damage the gut lining, increase metabolic demands, and suppress appetite. This combination can cause malnutrition, delayed puberty, and reduced bone density if inflammation remains uncontrolled. Height velocity, the rate at which a child grows yearly, is particularly sensitive to uncontrolled inflammation and typically improves once disease activity reduces.

Key aspects of managing IBD at home

Medication adherence

Consistent medication use forms the foundation of IBD management. Many paediatric IBD medications, including immunomodulators and biologics, reduce the immune system’s attack on the gut lining. Missing doses allows inflammation to return, even when your child feels well. Creating daily routines incorporating medication, whether tablets, liquids, or injections, establishes reliability. Older children can gradually assume more responsibility, but parental oversight remains important throughout adolescence.

Recognising flare symptoms

Knowing what a flare looks like enables earlier intervention. Common symptoms include increased stool frequency, blood or mucus in stools, abdominal pain, fatigue, and reduced appetite. Weight loss or growth plateau can also signal worsening inflammation. Distinguishing between symptoms from active inflammation and functional issues, such as irritable bowel syndrome, which can coexist with IBD, is important. Your gastroenterology team uses blood tests, stool markers such as faecal calprotectin, and sometimes endoscopy to assess true inflammatory activity.

Nutrition and growth monitoring

Adequate nutrition supports healing and development. Many children with IBD benefit from diets providing sufficient energy and protein whilst minimising gut irritants during active disease. Exclusive enteral nutrition (EEN), a liquid formula-only diet, is sometimes used to induce remission in paediatric Crohn’s disease, allowing bowel rest whilst providing complete nutrition. Regular monitoring of weight, height, and body mass index by your healthcare team identifies growth faltering early, enabling prompt interventions such as nutritional supplementation or treatment adjustments.

Supporting emotional wellbeing

Living with chronic illness affects a child’s sense of normality and self-image. They may feel different from peers, worry about accidents, or resent time spent on medical care. Open, age-appropriate communication helps children understand their body and feel more in control. Encouraging participation in school activities, friendships, and hobbies reinforces that they are more than their diagnosis. Access to psychological support, whether through the IBD team’s psychologist or external counselling, proves valuable when anxiety, low mood, or behavioural changes arise.

Coordinating with school

Teachers and staff need to understand your child’s condition to provide appropriate support. A healthcare plan outlining symptoms, medication schedules, toilet access, and emergency contacts ensures proper school response. Children with IBD should have unrestricted toilet access and leave class without questioning. During flares, fatigue or pain may affect concentration and attendance; maintaining teacher communication helps balance educational needs with health requirements.

Practical takeaways

• Establish consistent medication routines and involve your child in age-appropriate ways to encourage independence.
• Monitor symptoms and growth patterns, reporting changes to your gastroenterology team promptly rather than waiting for scheduled appointments.
• Provide balanced nutrition with sufficient energy and protein, and consider paediatric dietitian referral if growth or appetite concerns arise.
• Maintain open conversations about IBD and encourage your child to express worries or questions.
• Ensure school staff understand your child’s needs and have an agreed healthcare plan.
• Access psychological support when needed, recognising that chronic illness affects emotional and physical health.

Conclusion

Parenting a child with IBD requires balancing medical vigilance with allowing your child to live as fully as possible. Consistent medication adherence, early flare recognition, and attention to nutrition and growth form the management foundation. Equally important is supporting your child’s emotional wellbeing and ensuring they feel heard, understood, and included in care decisions. With coordinated input from your gastroenterology team, school, and family, most children with IBD can achieve stable disease control and continue to grow, learn, and thrive.

References

1. Ashton JJ, Gavin J, Beattie RM. Exclusive enteral nutrition in Crohn’s disease: evidence and practicalities. Clin Nutr. 2019;38(1):80-89. doi:10.1016/j.clnu.2018.01.020

1. Dhaliwal J, Walters TD, Mack DR, et al. Phenotypic variation in paediatric inflammatory bowel disease by age: a multicentre prospective inception cohort study of the Canadian Children IBD Network. J Crohn’s Colitis. 2020;14(4):445-454. doi:10.1093/ecco-jcc/jjz106

1. Greenley RN, Kunz JH, Schurman JV, Swanson E. Abdominal pain and health related quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol. 2013;38(1):63-71. doi:10.1093/jpepsy/jss097

1. Malik S, Ahmed SF, Wilson ML, et al. The effects of anti-TNF-alpha treatment with adalimumab on growth in children with Crohn’s disease (CD). J Crohn’s Colitis. 2012;6(3):337-344. doi:10.1016/j.crohns.2011.09.012

1. Ricciuto A, Aardoom M, Orlanski-Meyer E, et al. Predicting outcomes in pediatric Crohn’s disease for management optimization: systematic review and consensus statements from the Pediatric Inflammatory Bowel Disease-Ahead Program. Gastroenterology. 2021;160(1):403-436. doi:10.1053/j.gastro.2020.07.065

1. Timmer A, Behrens R, Buderus S, et al. Childhood onset inflammatory bowel disease: predictors of delayed diagnosis from the CEDATA German-language pediatric inflammatory bowel disease registry. J Pediatr. 2011;158(3):467-473. doi:10.1016/j.jpeds.2010.09.014

1. van Rheenen PF, Aloi M, Assa A, et al. The medical management of paediatric Crohn’s disease: an ECCO-ESPGHAN guideline update. J Crohn’s Colitis. 2021;15(2):171-194. doi:10.1093/ecco-jcc/jjaa161

1. Werkstetter KJ, Ullrich J, Schatz SB, et al. Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls. J Crohn’s Colitis. 2012;6(6):665-673. doi:10.1016/j.crohns.2011.11.017

This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.

More from Gastro Living